TERT and central nervous system cancer: Recent findings have established frequent mutations in the promoter region of telomerase reverse transcriptase (TERT) in a multitude of cancers, including melanomas, liposarcomas, bladder cancer, urinary tract cancers, and gliomas [13-19].